Table 3 MBL2 genotypes and infections in 72 patients with ASCT during the 6 months of follow-up
AA | AO/OO | RR (95% CI) | P-value* | |
|---|---|---|---|---|
Patients (%) | Patients (%) | |||
n = 53 | n = 19 | |||
Types of Infection | ||||
-Pneumonia | 2 (3.8) | 2 (10.5) | 2.8(0.4-18.4) | 0.28 |
-Sepsis | 22 (41.5) | 9 (47.4) | 1.1 (0.6-2.0) | 0.66 |
-VCI | 6 (11.3) | 2 (10.5) | 0.9 (0.2-4.2) | 1.00 |
-UTI | 5 (9.4) | 3 (15.8) | 1.7 (0.4-6.3) | 0.43 |
Major infection | 6 (11.3) | 5 (26.3) | 2.32 (0.80-6.74) | 0.15 |
Gram-positive infections | 14 (26.4) | 9 (47.4) | 1.8 (0.9-3.4) | 0.09 |
-S. epidermidis | 9 (17) | 7 (36.8) | 2.2 (0.9-5.0) | 0.11 |
-S. aureus | 1 (1.9) | 0 (0) | -- | 1.00 |
-Other | ||||
Gram-negative infections | 19 (35.8) | 6 (31.6) | 0.9 (0.4-1.9) | 0.74 |
Viral infections | 1 (1.9) | 1 (5.3) | 2.8 (0.2-42.4) | 0.46 |
-CMV | 0 (0) | 1 (5.3) | -- | 0.26 |
Fungal infections | 1 (1.9) | 4 (21.1) | 11.5 (1.3-93.7) | 0.016 |
- Candida | 1(1.9) | 2 (10.5) | 5.6 (0.5-58.1) | 0.17 |
- Aspergillus | 0 (0) | 1 (5.3) | -- | 0.26 |
-Mucor | 0 (0) | 1 (5.3) | -- | 0.26 |
Nº deaths | 4 (7.5) | 3 (15.8) | 2.1 (0.5-8.5) | 0.37 |
Cause of death | ||||
-Infection | 0 | 3 | -- | 0.05 |
-Progression | 3 | 0 | -- | |
-Unknown (not infection) | 1 | 0 | -- |